drugset / Trial / NCT00032929

Selegiline Transdermal System for the Treatment of Cocaine Dependence - 1

NCT00032929 ↗

RandomizedCrossoverQuadruple-blindTreatment

Summary

The purpose of this study is to evaluate the Selegiline Transdermal System for the treatment of cocaine dependence.

Timeline

Start
2001-03
Primary completion
2002-12
Completion
—

Outcome

Missed primary endpoint

paper Analysis of the data did not show a significant effect for selegiline over placebo. PMID 16730924 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Selegiline Unknown — Other

Indications